RU2015143676A3 - - Google Patents

Download PDF

Info

Publication number
RU2015143676A3
RU2015143676A3 RU2015143676A RU2015143676A RU2015143676A3 RU 2015143676 A3 RU2015143676 A3 RU 2015143676A3 RU 2015143676 A RU2015143676 A RU 2015143676A RU 2015143676 A RU2015143676 A RU 2015143676A RU 2015143676 A3 RU2015143676 A3 RU 2015143676A3
Authority
RU
Russia
Application number
RU2015143676A
Other languages
Russian (ru)
Other versions
RU2015143676A (ru
RU2679805C2 (ru
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/019126 external-priority patent/WO2014158654A1/en
Publication of RU2015143676A publication Critical patent/RU2015143676A/ru
Publication of RU2015143676A3 publication Critical patent/RU2015143676A3/ru
Application granted granted Critical
Publication of RU2679805C2 publication Critical patent/RU2679805C2/ru

Links

RU2015143676A 2013-03-14 2014-02-27 Модуляторы ship1 и относящиеся к ним способы RU2679805C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786020P 2013-03-14 2013-03-14
US61/786,020 2013-03-14
PCT/US2014/019126 WO2014158654A1 (en) 2013-03-14 2014-02-27 Ship1 modulators and methods related thereto

Publications (3)

Publication Number Publication Date
RU2015143676A RU2015143676A (ru) 2017-04-27
RU2015143676A3 true RU2015143676A3 (enExample) 2018-01-24
RU2679805C2 RU2679805C2 (ru) 2019-02-13

Family

ID=50288307

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015143676A RU2679805C2 (ru) 2013-03-14 2014-02-27 Модуляторы ship1 и относящиеся к ним способы

Country Status (14)

Country Link
US (2) US9765085B2 (enExample)
EP (1) EP2970122B1 (enExample)
JP (1) JP6407951B2 (enExample)
KR (3) KR20220110337A (enExample)
CN (2) CN108892637A (enExample)
AU (1) AU2014242041B2 (enExample)
BR (1) BR112015023009A2 (enExample)
CA (1) CA2902768A1 (enExample)
ES (1) ES2740779T3 (enExample)
IL (1) IL240968A0 (enExample)
MX (1) MX2015012111A (enExample)
RU (1) RU2679805C2 (enExample)
WO (1) WO2014158654A1 (enExample)
ZA (1) ZA201506674B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015133177A (ru) 2013-01-09 2017-02-14 Экуинокс Фармасьютикалз (Кэнэда) Инк. Модуляторы ship1 и связанные с ними способы
US10100056B2 (en) 2013-03-14 2018-10-16 Aquinox Pharmaceuticals (Canada) Inc. SHIP1 modulators and methods related thereto
EP2970122B1 (en) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators
EP3313811A1 (en) * 2015-06-26 2018-05-02 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
JP2019508424A (ja) * 2016-03-02 2019-03-28 パセオン オーストリア ゲーエムベーハー ウント ツェーオー カーゲー 17(20)−エン b−セコステロイドの生産のためのプロセスと中間体
WO2018126040A1 (en) 2016-12-28 2018-07-05 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3- (hydroxymethyl)-4-methylcyclohexanol
JP2021526545A (ja) * 2018-04-06 2021-10-07 アキノックス ファーマシューティカルス(カナダ)インク. 疼痛及び炎症を治療するのに有用なインデン誘導体
JP2021526546A (ja) * 2018-04-06 2021-10-07 アキノックス ファーマシューティカルス(カナダ)インク. 疼痛及び炎症を治療するのに有用なインデン誘導体
WO2019195692A1 (en) * 2018-04-06 2019-10-10 Aquinox Pharmaceuticals (Canada) Inc. Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation
CN112940062B (zh) * 2021-02-23 2022-09-06 浙江神洲药业有限公司 一种16-去氢黄体酮的制备方法
CN117024374A (zh) * 2023-08-08 2023-11-10 安庆百谊生物科技有限公司 一种3-甲基-1,2,4-噻二唑-5-碳酰肼或其盐的合成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1084718B (de) 1958-07-08 1960-07-07 Bayer Ag Verfahren zur Herstellung von Secosteroiden
SE345995B (enExample) 1969-01-31 1972-06-19 Bristol Myers Co
US3682983A (en) 1969-11-12 1972-08-08 Klaus Prezewowsky Preparation of {66 {11 {11 -17 ethinyl steroids
US3869467A (en) 1972-06-05 1975-03-04 Hoffmann La Roche 17-{62 -Hydroxy-17-{60 -methyl-5-{60 -androstano{9 3,2-c{9 or{8 2,3-d{9 isoxazoles
US3962275A (en) 1972-06-05 1976-06-08 Hoffmann-La Roche Inc. 7-oxa steroids
JPH01290624A (ja) 1988-05-16 1989-11-22 Shiono Chem Kk 5,6―セコ―ステロール誘導体血清脂質低下剤
JPH07502511A (ja) 1991-12-20 1995-03-16 グラクソ、インコーポレーテッド 5‐α‐テストステロンレダクターゼ阻害剤
JPH05221924A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール化合物
JPH05221901A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール誘導体
US5464866A (en) 1992-08-17 1995-11-07 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AP459A (en) 1992-12-18 1996-02-14 Glaxo Wellcome Inc Substituted 6-azaandrostenones.
AU699200B2 (en) 1993-07-09 1998-11-26 Roger Bouillon Novel structural analogues of vitamin D
US5541322A (en) 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6046185A (en) 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
EP1118654A4 (en) 1999-04-16 2007-03-07 Nippon Mitsubishi Oil Corp TRANSMISSION FLUID
SK15692002A3 (sk) 2000-04-28 2003-11-04 Inflazyme Pharmaceuticals Limited 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie
US6696580B2 (en) 2001-05-22 2004-02-24 Inflazyme Pharmaceuticals Ltd. Process for the production of 6,7-diols of steroidal compounds
CA2463136A1 (en) 2001-10-17 2003-04-24 Raymond Andersen Ship 1 modulators
JP4753581B2 (ja) 2002-10-17 2011-08-24 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア Ship1モデュレーター
CN1805915A (zh) 2003-04-15 2006-07-19 茵弗莱采姆药物有限公司 作为药物活性剂的茚衍生物
WO2007147252A1 (en) 2006-06-21 2007-12-27 The University Of British Columbia Ship 1 modulator prodrugs
WO2008038965A1 (en) * 2006-09-26 2008-04-03 Kyungpook National University Industry-Academic Cooperation Foundation 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient
US8101605B2 (en) * 2009-12-04 2012-01-24 Aquinox Pharmaceuticals Inc. SHIP1 modulators and methods related thereto
EP2605767B1 (en) 2010-08-20 2016-07-27 The University Of British Columbia Ship1 modulators and related methods
WO2012082750A1 (en) * 2010-12-13 2012-06-21 Rutgers University Methods of producing and using brassinosteroids to promote growth, repair and maintenance of skeletal muscle and skin
US10100056B2 (en) 2013-03-14 2018-10-16 Aquinox Pharmaceuticals (Canada) Inc. SHIP1 modulators and methods related thereto
EP2970122B1 (en) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators
EP3313811A1 (en) 2015-06-26 2018-05-02 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
WO2018058144A1 (en) 2016-09-26 2018-03-29 Aquinox Pharmaceuticals (Canada) Inc. Ship1 activator for treating prostatis

Similar Documents

Publication Publication Date Title
BR112021000792B8 (enExample)
AT524874A5 (enExample)
AT524834A2 (enExample)
AU2018438767B1 (enExample)
AT521543A3 (enExample)
AT524961A5 (enExample)
AT524266A2 (enExample)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019025884B1 (pt) Sistema de segurança aprimorado para máquinas de operação de autopropulsão
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112021001434B1 (pt) Aço com alto teor de manganês e método de produção do mesmo
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112021001186B1 (pt) Aparelho para o tratamento de celulite para tratar expressões de celulite na pele de um paciente associadas a um local de tratamento de septos
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020024987B1 (pt) Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico
BR112020023823B1 (pt) Distribuidor
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020022516B1 (pt) Processo para degomagem enzimática de óleo
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas
BR112020020812B1 (pt) Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado
BR112020015757B1 (pt) Métodos, sistema, kit e dispositivos para visualização e remoção de tumor
BR102019000241B1 (pt) Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados